Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers
Authors:
- Jamaal C. JacksonJJJamaal C. Jackson
- Darren SanchezDSDarren Sanchez
- Aron Y. JoonAJAron Y. Joon
- Marcos R. EstecioMEMarcos R. Estecio
- Andrew C. JohnsAJAndrew C. Johns
- Amishi Y. ShahASAmishi Y. Shah
- Matthew CampbellMCMatthew Campbell
- John F. WardJWJohn F. Ward
- Louis L. PistersLPLouis L. Pisters
- Charles C. GuoCharles C. Guo
- Miao ZhangMZMiao Zhang
- Niki M. ZachariasNiki M. Zacharias
Open Access
Abstract
Germ cell tumors of the testis (GCTs) provide an ideal tumor model to investigate the cellular versus genetic origin of cancers. In this single institutional study, we evaluated 38 patients with bilateral GCT, including tumors that occurred simultaneously (synchronous) and those occurring at different times (metachronous). For nine of these patients, DNA was isolated from the right and left GCT to determine the genomic and epigenetic differences between tissues using whole-exome sequencing (WES) and reduced representation bisulfite sequencing (RRBS). We found that seminomas and non-seminomas are molecularly distinct based on DNA methylation and not due to synchronous or metachronous disease. In addition, we did not observe conservation of genetic mutations in right and left GCT in either synchronous or metachronous disease. Our data suggest a cellular origin for bilateral GCT.Keywords
Funding Information
- The University of Texas MD Anderson Cancer Center
- the Partnership for Careers in Cancer Science and Medicine Program in the Division of Education and Training at the University of Texas MD Anderson Cancer Center
- The University of Texas MD Anderson Cancer Center and the Center for Cancer Epigenetics
This publication has 60 references indexed in Scilit:
- Bilateral Mastectomy and Breast Cancer MortalityJAMA Oncology, 2024
- Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancerCancer, 2016
- Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in SeminomasEuropean Urology, 2015
- The corticotropin releasing factor system in cancer: expression and pathophysiological implicationsCellular and Molecular Life Sciences, 2010
- Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: Report of 220 tumors and review of literatureGenes, Chromosomes and Cancer, 2007
- Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancerGenes, Chromosomes and Cancer, 2006
- KIT Mutations Are Common in Testicular SeminomasThe American Journal of Pathology, 2004
- Identical Allelic Losses in Mature Teratoma and Other Histologic Components of Malignant Mixed Germ Cell Tumors of the TestisThe American Journal of Pathology, 2003
- Stem-cell origin of metastasis and heterogeneity in solid tumoursThe Lancet Oncology, 2002
- MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumorsCancer, 2001